HUYABIO International
Jill Ricono is currently the Director of Biology at HUYA Bioscience International. Previously, Jill worked as a Principal Consultant at Ricono Consulting, Director of Translational Oncology at Crown Bioscience, Inc., Associate Director In vivo Pharmacology/Associate Director R&D at Molecular Response, and in various research positions at UCSD, The Scripps Research Institute, The University of Texas Health Science Center at San Antonio, and New Mexico State University. Jill holds a PhD in Molecular Medicine from UT Health San Antonio and a BS from Creighton University.
HUYABIO International
HUYABIO is the leader in accelerating the global development of novel biopharmaceutical product opportunities originating in China enabling faster, more cost-effective and lower-risk drug development in the global markets. Through extensive collaboration with biopharmaceutical, academic and commercial organizations, it has built the largest China-sourced compound portfolio covering all therapeutic areas. With offices in the US, Japan, South Korea, Canada, Ireland and eight strategic locations across China, the Company has become a partner of choice to accelerate product development and maximize value globally.